Mentor Capital Inc. (MNTR) 1.0100 $MNTR
Mentor Capital's MicroCannaBiz Sees Revenues in Fourth Month
Marketwire - Fri Jun 13, 1:05PM CDT
Mentor Capital, Inc. (OTC Pink: MNTR) (PINKSHEETS: MNTR) announced today that its portfolio subsidiary MicroCannaBiz, LLC, has transitioned from start-up to revenue generation. With initial and expansion funding provided by Mentor Capital, MicroCannaBiz was formed in February to address the legal cannabis market by Financial Research Solutions, Inc., a media, microcap investment research and educational training company.
Mentor Capital Issues First Quarter Financials with $535k Revenue
Business Wire - Thu Jun 05, 9:41AM CDT
Mentor Capital, Inc. (OTC Markets: MNTR) announced its first quarter consolidated operating results today in preparation to audit submission. The complete financial filing can be viewed at the company's Filings and Disclosure page at the OTCMarkets.com website under the Mentor Capital ticker (MNTR).
Mentor Capital Provides Seed Finance for Nevada Cannabis Fund
Business Wire - Tue Jun 03, 7:54AM CDT
Mentor Capital, Inc. (OTC Markets: MNTR) announced that it has provided seed funding to help launch an independently managed cannabis focused fund based in Nevada. The fund anticipates making marijuana related investments in Nevada and in other locals.
Mentor Capital Funds Bhang Financial for Cannabis Card Processing
Business Wire - Mon Jun 02, 9:49AM CDT
Mentor Capital, Inc. (OTC: MNTR) announced that its portfolio company, Bhang Corporation, has established Bhang Financial to offer the Cannabis Community non-cash payment options with Cashless ATMs for PIN Debit Network transactions and ATMs. The new Bhang division will also offer fully integrated Point of Sale (POS) software solutions to enable clients to maintain inventory and track sales efficiently.
Mentor Capital Hires for Growing Cannabis Business
Marketwire - Thu May 29, 1:21PM CDT
Mentor Capital, Inc. (OTC Pink: MNTR) (PINKSHEETS: MNTR) announced its stated goal of progressing to be an operating medical marijuana NASDAQ company took another step forward with the appointment of public accounting veteran Lori J. Stansfield, CPA as company CFO. "Having taught, authored, audited and managed every aspect of accounting organizations, it's a career capping challenge to be given responsibility to create and deliver quality public financial disclosure across a growing portfolio in such a young sector," says Ms. Stansfield. "As a Colorado native and mother seeking the benefits of CBD for her daughter, I am pleased to be part of the Mentor Capital team that is making a difference here in the right way."
Mentor Capital Targets $100 Million for Marijuana Investments from Call of Series D Warrants
Business Wire - Wed Mar 12, 11:49AM CDT
Mentor Capital, Inc. (OTC Markets: MNTR) announced that it is Calling its 15 Million Series D ($7) warrants at their long-standing strike price of $7.00 per share, and in this fashion targets to raise $100 Million for marijuana related investments. These warrants are already in the hands of Mentor Capital's original 1,500 mostly accredited investors. The call period is through June 30th, 2014.
Mentor Capital Acquires 60% of Bhang Chocolate for $39 Million
Business Wire - Tue Mar 11, 11:11AM CDT
Mentor Capital, Inc. (OTC Markets: MNTR) announced today that it has been selected by Bhang Chocolate Company, Inc. to provide $39 Million in equity funding for Bhang's national and international expansion and to help further extend their market-leading brand across the marijuana related sector. Mentor Capital CEO, Chet Billingsley, affirms, "By a wide margin, five time cannabis cup winner, Bhang Chocolate is recognized as the world's singular leading cannabis brand. We feel privileged to be working with the Bhang management team lead by founder Scott Van Rixel. In the explosively growing and sometimes chaotic environment accompanying marijuana legalization, they provide a bulwark of business professionalism and integrity in the delivery of Bhang's gourmet medicinal chocolates and growing infused edible selections."
WEALTHMAKERS.COM Issues Report on Mentor Capital
M2 - Mon Mar 10, 8:54AM CDT
March 10, 2014 / M2 PRESSWIRE / WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued a new research report today on Mentor Capital (OTC: MNTR). The report highlights the short term bullish pattern that has emerged, the SqueezeTrigger Price of $2.54 and the projected short squeeze price target of $19.59 per share.
Mentor Capital Catches Market Makers Selling 250% of Shares
Marketwire - Tue Feb 25, 11:50AM CST
Mentor Capital, Inc. (OTC Pink: MNTR) announces that BuyIns.Net has uncovered that Shorts have sold 5.5 Million of the 2.2 Million (sic.) Mentor Capital, Inc. shares in the float and available to trade. In response to this situation, Mentor Capital Inc.'s CEO, Chet Billingsley comments, "For 2014 we retained BuyIns.Net, who monitors all stock trades for illegal short selling activity, soon after 50% of our float suspiciously traded in two hours." According to his web site, BuyIns.Net founder, Tom Ronk, entered into a business partnership with former SEC Chairman, Harvey Pitt. They spearheaded the passage of Regulation SHO that, if followed, helps safeguard public companies from these sorts of short selling issues.
BUYINS.NET Issues Mentor Capital SqueezeTrigger Report
M2 - Tue Feb 25, 2:34AM CST
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on Mentor Capital (OTC: MNTR) after releasing the latest short sale data through February 21, 2014. The total aggregate number of shares shorted since August 2009 is approximately 3.45 million shares. Approximately 41.09% of daily trading volume is short selling. The SqueezeTrigger price for all MNTR shares shorted is $1.53. A short squeeze has just begun as shares of MNTR closed above the $1.53 SqueezeTrigger price.
Mentor Capital Acquires 51% Stake in MicroCannaBiz, LLC
Business Wire - Thu Feb 20, 12:54PM CST
Mentor Capital, Inc. (OTC Markets: MNTR) announced today that it has acquired a 51% equity interest in MicroCannaBiz, LLC, which was recently formed to address the legal cannabis market by Financial Research Solutions, Inc., a media, microcap investment research and educational training company.
Mentor Capital Agrees to $2M Backing for Cannabis Advocacy Business
Business Wire - Mon Jan 27, 7:30AM CST
Mentor Capital, Inc. (OTC Markets: MNTR) announced that it has agreed to provide $2 Million in funding for The Cannabis Advocacy Machine. Mentor Capital CEO, Chester Billingsley, explains that behind any political initiative there is a commercial enterprise in the business of developing data and statistics, directing advertisement, and maintaining proprietary software systems. The Cannabis Advocacy Machine, a division of The Machine Corporation, is providing Moneyball-like direction and support that is key to that process for the legalization of cannabis across the country. "Signing a letter of intent for 20% of The Machine Corporation under the nationally experienced leadership of the first tier team with Joe Brezny, aims to accelerate the legislative initiatives critical to the lifting of marijuana prohibition, in what may be a surprisingly profitable manner."
Mentor Capital Cannabis Index Up 325% in First Three Weeks of 2014
Business Wire - Wed Jan 22, 10:25AM CST
Mentor Capital, Inc. (OTCMKTS:MNTR) reports that its proprietary Cannabis Index appreciated 325% during the first three weeks of 2014. The overall positive and profitable experience for marijuana based businesses and taxing authorities alike is thought to be a key driver in this sector-wide advance.
Mentor Capital Cancer Immunotherapy Index Up 97% in 2013
Business Wire - Tue Jan 21, 10:01AM CST
Mentor Capital, Inc. (OTCMKTS:MNTR) reports that its proprietary Cancer Immunotherapy Index appreciated 97.4% during 2013. The equally weighted Cancer Immunotherapy Index is regularly benchmarked against the appreciation of the average of the NASDAQ, S&P, and NYSE Biotech Indices. For the same 2013 annual period the biotech indices averaged a 54.8% gain.
Mentor Capital Says HempCon to be First Funded from New Public Cannabis Fund
Business Wire - Fri Jan 17, 12:40PM CST
Mentor Capital, Inc. (OTC Markets:MNTR) announced its first major acquisition for cannabis funding will be HempCon, Inc. That medical marijuana convention company is hosting hemp industry pioneers at the San Jose Convention Center January 17-19th. The agreement by principals and letter of intent outlines that HempCon, Inc. will receive $7.0 Million from Mentor Capital investors plus future public market appreciation for a 100% interest. Positioning HempCon to be the first to be funded by the first operating public cannabis fund of its kind should be wholly credited to savvy action by HempCon founder Edwin Kwong, who had already been approached by two other public companies, reports Mentor Capital CEO Chester Billingsley.
Mentor Capital, Inc. Funds Completion of 12.5% Stock Buyback
Business Wire - Thu Sep 05, 1:56PM CDT
Mentor Capital, Inc. (OTCMKTS:MNTR) has deposited funds with its broker to complete the final tranche of its multi-year stock repurchase program. In 2008, Mentor Capital, Inc. committed to the repurchase of 12.5% of its then outstanding common stock and is positioned to wrap-up that stock buy-back now.
Mentor Capital Cancer Immunotherapy Index Gains 31% During First Half of 2013
Business Wire - Fri Jul 19, 12:49PM CDT
Mentor Capital, Inc. (Pink Sheets:MNTR) reports that its proprietary Cancer Immunotherapy Index appreciated 30.6% during the first half of 2013. The equally weighted Cancer Immunotherapy Index is regularly benchmarked against the appreciation of the average of the NASDAQ, S&P, and NYSE Biotech Indices. For the first half the biotech indices averaged a 34.5% gain.
Mentor Capital's MicroCannaBiz Sees Revenues in Fourth Month
Marketwire - Fri Jun 13, 1:05PM CDT
Mentor Capital, Inc. (OTC Pink: MNTR) (PINKSHEETS: MNTR) announced today that its portfolio subsidiary MicroCannaBiz, LLC, has transitioned from start-up to revenue generation. With initial and expansion funding provided by Mentor Capital, MicroCannaBiz was formed in February to address the legal cannabis market by Financial Research Solutions, Inc., a media, microcap investment research and educational training company.
Mentor Capital Issues First Quarter Financials with $535k Revenue
Business Wire - Thu Jun 05, 9:41AM CDT
Mentor Capital, Inc. (OTC Markets: MNTR) announced its first quarter consolidated operating results today in preparation to audit submission. The complete financial filing can be viewed at the company's Filings and Disclosure page at the OTCMarkets.com website under the Mentor Capital ticker (MNTR).
Mentor Capital Provides Seed Finance for Nevada Cannabis Fund
Business Wire - Tue Jun 03, 7:54AM CDT
Mentor Capital, Inc. (OTC Markets: MNTR) announced that it has provided seed funding to help launch an independently managed cannabis focused fund based in Nevada. The fund anticipates making marijuana related investments in Nevada and in other locals.
Mentor Capital Funds Bhang Financial for Cannabis Card Processing
Business Wire - Mon Jun 02, 9:49AM CDT
Mentor Capital, Inc. (OTC: MNTR) announced that its portfolio company, Bhang Corporation, has established Bhang Financial to offer the Cannabis Community non-cash payment options with Cashless ATMs for PIN Debit Network transactions and ATMs. The new Bhang division will also offer fully integrated Point of Sale (POS) software solutions to enable clients to maintain inventory and track sales efficiently.
Mentor Capital Hires for Growing Cannabis Business
Marketwire - Thu May 29, 1:21PM CDT
Mentor Capital, Inc. (OTC Pink: MNTR) (PINKSHEETS: MNTR) announced its stated goal of progressing to be an operating medical marijuana NASDAQ company took another step forward with the appointment of public accounting veteran Lori J. Stansfield, CPA as company CFO. "Having taught, authored, audited and managed every aspect of accounting organizations, it's a career capping challenge to be given responsibility to create and deliver quality public financial disclosure across a growing portfolio in such a young sector," says Ms. Stansfield. "As a Colorado native and mother seeking the benefits of CBD for her daughter, I am pleased to be part of the Mentor Capital team that is making a difference here in the right way."
Mentor Capital Targets $100 Million for Marijuana Investments from Call of Series D Warrants
Business Wire - Wed Mar 12, 11:49AM CDT
Mentor Capital, Inc. (OTC Markets: MNTR) announced that it is Calling its 15 Million Series D ($7) warrants at their long-standing strike price of $7.00 per share, and in this fashion targets to raise $100 Million for marijuana related investments. These warrants are already in the hands of Mentor Capital's original 1,500 mostly accredited investors. The call period is through June 30th, 2014.
Mentor Capital Acquires 60% of Bhang Chocolate for $39 Million
Business Wire - Tue Mar 11, 11:11AM CDT
Mentor Capital, Inc. (OTC Markets: MNTR) announced today that it has been selected by Bhang Chocolate Company, Inc. to provide $39 Million in equity funding for Bhang's national and international expansion and to help further extend their market-leading brand across the marijuana related sector. Mentor Capital CEO, Chet Billingsley, affirms, "By a wide margin, five time cannabis cup winner, Bhang Chocolate is recognized as the world's singular leading cannabis brand. We feel privileged to be working with the Bhang management team lead by founder Scott Van Rixel. In the explosively growing and sometimes chaotic environment accompanying marijuana legalization, they provide a bulwark of business professionalism and integrity in the delivery of Bhang's gourmet medicinal chocolates and growing infused edible selections."
WEALTHMAKERS.COM Issues Report on Mentor Capital
M2 - Mon Mar 10, 8:54AM CDT
March 10, 2014 / M2 PRESSWIRE / WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued a new research report today on Mentor Capital (OTC: MNTR). The report highlights the short term bullish pattern that has emerged, the SqueezeTrigger Price of $2.54 and the projected short squeeze price target of $19.59 per share.
Mentor Capital Catches Market Makers Selling 250% of Shares
Marketwire - Tue Feb 25, 11:50AM CST
Mentor Capital, Inc. (OTC Pink: MNTR) announces that BuyIns.Net has uncovered that Shorts have sold 5.5 Million of the 2.2 Million (sic.) Mentor Capital, Inc. shares in the float and available to trade. In response to this situation, Mentor Capital Inc.'s CEO, Chet Billingsley comments, "For 2014 we retained BuyIns.Net, who monitors all stock trades for illegal short selling activity, soon after 50% of our float suspiciously traded in two hours." According to his web site, BuyIns.Net founder, Tom Ronk, entered into a business partnership with former SEC Chairman, Harvey Pitt. They spearheaded the passage of Regulation SHO that, if followed, helps safeguard public companies from these sorts of short selling issues.
BUYINS.NET Issues Mentor Capital SqueezeTrigger Report
M2 - Tue Feb 25, 2:34AM CST
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on Mentor Capital (OTC: MNTR) after releasing the latest short sale data through February 21, 2014. The total aggregate number of shares shorted since August 2009 is approximately 3.45 million shares. Approximately 41.09% of daily trading volume is short selling. The SqueezeTrigger price for all MNTR shares shorted is $1.53. A short squeeze has just begun as shares of MNTR closed above the $1.53 SqueezeTrigger price.
Mentor Capital Acquires 51% Stake in MicroCannaBiz, LLC
Business Wire - Thu Feb 20, 12:54PM CST
Mentor Capital, Inc. (OTC Markets: MNTR) announced today that it has acquired a 51% equity interest in MicroCannaBiz, LLC, which was recently formed to address the legal cannabis market by Financial Research Solutions, Inc., a media, microcap investment research and educational training company.
Mentor Capital Agrees to $2M Backing for Cannabis Advocacy Business
Business Wire - Mon Jan 27, 7:30AM CST
Mentor Capital, Inc. (OTC Markets: MNTR) announced that it has agreed to provide $2 Million in funding for The Cannabis Advocacy Machine. Mentor Capital CEO, Chester Billingsley, explains that behind any political initiative there is a commercial enterprise in the business of developing data and statistics, directing advertisement, and maintaining proprietary software systems. The Cannabis Advocacy Machine, a division of The Machine Corporation, is providing Moneyball-like direction and support that is key to that process for the legalization of cannabis across the country. "Signing a letter of intent for 20% of The Machine Corporation under the nationally experienced leadership of the first tier team with Joe Brezny, aims to accelerate the legislative initiatives critical to the lifting of marijuana prohibition, in what may be a surprisingly profitable manner."
Mentor Capital Cannabis Index Up 325% in First Three Weeks of 2014
Business Wire - Wed Jan 22, 10:25AM CST
Mentor Capital, Inc. (OTCMKTS:MNTR) reports that its proprietary Cannabis Index appreciated 325% during the first three weeks of 2014. The overall positive and profitable experience for marijuana based businesses and taxing authorities alike is thought to be a key driver in this sector-wide advance.
Mentor Capital Cancer Immunotherapy Index Up 97% in 2013
Business Wire - Tue Jan 21, 10:01AM CST
Mentor Capital, Inc. (OTCMKTS:MNTR) reports that its proprietary Cancer Immunotherapy Index appreciated 97.4% during 2013. The equally weighted Cancer Immunotherapy Index is regularly benchmarked against the appreciation of the average of the NASDAQ, S&P, and NYSE Biotech Indices. For the same 2013 annual period the biotech indices averaged a 54.8% gain.
Mentor Capital Says HempCon to be First Funded from New Public Cannabis Fund
Business Wire - Fri Jan 17, 12:40PM CST
Mentor Capital, Inc. (OTC Markets:MNTR) announced its first major acquisition for cannabis funding will be HempCon, Inc. That medical marijuana convention company is hosting hemp industry pioneers at the San Jose Convention Center January 17-19th. The agreement by principals and letter of intent outlines that HempCon, Inc. will receive $7.0 Million from Mentor Capital investors plus future public market appreciation for a 100% interest. Positioning HempCon to be the first to be funded by the first operating public cannabis fund of its kind should be wholly credited to savvy action by HempCon founder Edwin Kwong, who had already been approached by two other public companies, reports Mentor Capital CEO Chester Billingsley.
Mentor Capital, Inc. Funds Completion of 12.5% Stock Buyback
Business Wire - Thu Sep 05, 1:56PM CDT
Mentor Capital, Inc. (OTCMKTS:MNTR) has deposited funds with its broker to complete the final tranche of its multi-year stock repurchase program. In 2008, Mentor Capital, Inc. committed to the repurchase of 12.5% of its then outstanding common stock and is positioned to wrap-up that stock buy-back now.
Mentor Capital Cancer Immunotherapy Index Gains 31% During First Half of 2013
Business Wire - Fri Jul 19, 12:49PM CDT
Mentor Capital, Inc. (Pink Sheets:MNTR) reports that its proprietary Cancer Immunotherapy Index appreciated 30.6% during the first half of 2013. The equally weighted Cancer Immunotherapy Index is regularly benchmarked against the appreciation of the average of the NASDAQ, S&P, and NYSE Biotech Indices. For the first half the biotech indices averaged a 34.5% gain.
